bit.bio

Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development.

Health and bio Data and analytics

Latest funding

$25M Series B+ · November 4, 2026

Source: bit.bio

Total raised: $75M across 2 sourced rounds

All 3 rounds ↓

Website: bit.bio.

X: @bitbio · 1,735 followers.

LinkedIn: linkedin.com.

Categories: Health and bio Data and analytics.

Sectors: Analytics, Biotechnology, Health Care, Test and Measurement.

Stage: Series B+.

Based in: Cambridge, United Kingdom.

Founded: 2016.

Total raised: $75M in 2 sourced rounds.

Last round: Nov 4, 2026 · 8 days ago.

Headcount: 101–250 employees.

On Recent Funding since: Nov 5, 2026.

Signals

X account@bitbio · created Feb 7, 2018 (8 years old) · 1,735 followers

Website registeredFeb 27, 2019 (7 years old)

TIMELINE · MONEY RAISED

bit.bio | 1367 days from X account to first raise on record

@bitbio·Raised $75M in 2 sourced rounds·2 signals before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

November 4, 2026
Series B+ · $25M
JJonathan Milner, MM&G Investments
Source: bit.bio
January 9, 2026
Series B+ · $50M
MM&G Investments (lead), DDynamk Capital
Source: bit.bio
November 5, 2021
Series B+ · amount undisclosed
AArchVentures SA, CCharles River Laboratories International, FForesite Capital, GGood AI Capital, HHarmonix Fund, MMetaplanet Holdings, MMilad Alucozai, PPuhua Capital, RResilience, TTencent
Source: finance.yahoo.com
February 27, 2019
Website created
February 7, 2018
X account created

Founders and team

FS
Florian Schuster Founder

LinkedIn
MK
Mark Kotter Founder

LinkedIn
EP
Emma Pepperell CEO
PO
Przemek Obloj CEO
GB
Grant Belgard VP, Bioinformatics
PG
Paul Grafham Financial Controller
PM
Paul Morrill Chief Business Officer
SS
Sejla Salic-Hainzl Chief Technology Officer

Investors

Companies like bit.bio

OOwkin
IIDRx$120M Series B+ · Aug 2024
HHotSpot Therapeutics$100M Series B+ · Nov 2021
LLightcast$27M Series B+ · Apr 2026
WWhiteLab Genomics$26M Series B+ · Oct 2026
1100XBIOPre Seed · Oct 2026

Other companies backed by M&G Investments

TTractian$130M Series B+ · Oct 2026
PPixxel$100M Series B+ · Sep 2026
NNearfield Instruments$380M Series B+ · Jun 2026
PPhysicsX$300M Series B+ · Jun 2026
MMainspring Energy$258M Series B+ · Apr 2025
SSubmer$55.5M Series A · Nov 2024

M&G Investments portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/bit-bio (get a free API key).